Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Fire breaks out at Kuwaiti refinery after drone attacks
UK says vaccine protects against strain in deadly meningitis outbreak
Tropical Cyclone Narelle weakens after lashing Australia's northeast with winds, rain
More than 50 injured in fire at car parts factory in South Korea
Four countries condemn Iranian attack on Ras Laffan in Qatar
